Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder
Cyclin-dependent kinase-like 5 (CDKL5, also known as STK9) is a serine/threonine protein kinase originally identified in 1998 during a transcriptional mapping project of the human X chromosome. Thereafter, a mutation in CDKL5 was reported in individuals with the atypical Rett syndrome, a neurodevelo...
Saved in:
Main Authors: | Syouichi Katayama, Noriyuki Sueyoshi, Tetsuya Inazu, Isamu Kameshita |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2020/6970190 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder
by: Claudia Fuchs, et al.
Published: (2018-01-01) -
A case of CDKL5 deficiency disorder with a novel intragenic multi-exonic duplication
by: Takato Akiba, et al.
Published: (2024-11-01) -
CDKL5 deficiency disorder in an infant presenting as drug-refractory epilepsy after TdaP-Hib-IPV vaccination: A case report
by: Hong-Yu Chen, et al.
Published: (2025-01-01) -
Retraction Note: Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion
by: Weiyi Li, et al.
Published: (2025-02-01) -
Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus
by: Danish Ahmed, et al.
Published: (2011-01-01)